DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Piramal Pharma Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 51 min ago·16 Oct 2026, 6:56 am

Piramal Pharma

Piramal Pharma Limited has announced the schedule for its upcoming meeting with analysts and institutional investors. This event provides a platform for the company's leadership to discuss its current business strategy, operational progress, and future outlook with the financial community.

For investors, such meetings are a key opportunity to gain direct insights into management's thinking and assess the company's trajectory. It helps clarify the company's direction, particularly in a competitive sector, and allows investors to gauge management's confidence in its growth plans.

Investors should watch for updates on the company's strategic priorities, including any commentary on its pharma and healthcare businesses. Following the meeting, the market will likely react to any new information or guidance provided by the company.